MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodward, R. M.
Right arrow Articles by Miledi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodward, R. M.
Right arrow Articles by Miledi, R.

Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors

RM Woodward, L Polenzani and R Miledi

Department of Psychobiology, University of California, Irvine 92717- 4550.

Poly(A)+ RNA from bovine retina expressed gamma-aminobutyric acid (GABA)-activated membrane current responses in Xenopus oocytes, consisting of two pharmacologically distinct components. One component (IG-Aret) was mediated by GABAA receptors, and the other component (KG- BR) by atypical GABA receptors that were resistant to inhibition by bicuculline and insensitive to activation by baclofen. To further characterize the bicuculline/baclofen-insensitive GABA receptors, electrical recordings were made measuring the sensitivity of IG-BR to two Cl- channel inhibitors, t-butylbicyclophosphorothionate (TBPS) and picrotoxin. For purposes of comparison, effects of TBPS and picrotoxin were also assayed on currents mediated by GABAA receptors expressed in oocytes by rat cerebral cortex RNA (IG-Actx). The main finding of this study was that TBPS was a surprisingly weak inhibitor of IG-BR, whereas IG-Actx was potently suppressed. Assays on maximum responses indicated that IG-Actx was at least 500 times more sensitive to TBPS than was IG- BR (IC50 values of approximately 0.2 microM and greater than 50 microM, respectively). Moreover, inhibition of IG-Actx by micromolar concentrations of TBPS was largely insurmountable, whereas the weak inhibitory effects on IG-BR showed strong dependence on agonist concentration. For example, 10 microM TBPS reduced maximum IG-Actx by greater than 90%, an effect that was not significantly reversed by 10- fold increases in the concentration of agonist. In contrast, the same concentration of TBPS caused a 2-fold increase in the EC50 for IG-BR but had only marginal (less than 5%) inhibitory effects on maximum responses. Picrotoxin inhibited both types of current, but assays on maximum responses indicated that IG-Actx was approximately 30 times more sensitive than IG-BR (IC50 values of approximately 1 and 30 microM, respectively). Inhibitory effects of picrotoxin on IG-BR again showed strong dependence on agonist concentration, but in this case there was also a clear insurmountable component. Comparisons between IG- Actx and IG-Aret suggested that GABAA receptors expressed by either brain or retina RNA showed approximately the same sensitivity to TBPS and picrotoxin. Our experiments indicate that the bicuculline/baclofen- insensitive GABA receptors expressed by retina RNA differ markedly from GABAA receptors in their sensitivity to TBPS and picrotoxin. Defining the structural features responsible for these differences at the molecular level will provide a further means of investigating the complex mechanisms underlying interactions between inhibitors and GABA- activated Cl- channels.

Volume 42, Issue 1, pp. 165-173, 07/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. Qian, Y. Pan, Y. Zhu, and P. Khalili
Picrotoxin Accelerates Relaxation of GABAC Receptors
Mol. Pharmacol., February 1, 2005; 67(2): 470 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. I. Torres and D. S. Weiss
Identification of a Tyrosine in the Agonist Binding Site of the Homomeric rho 1 gamma -Aminobutyric Acid (GABA) Receptor That, When Mutated, Produces Spontaneous Opening
J. Biol. Chem., November 8, 2002; 277(46): 43741 - 43748.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev, April 1, 2002; 82(2): 503 - 568.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martínez-Torres and R. Miledi
Expression of gamma -aminobutyric acid rho 1 and rho 1Delta 450 as gene fusions with the green fluorescent protein
PNAS, February 1, 2001; (2001) 31584898.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Perret, X. Sarda, M. Wolff, T.-T. Wu, D. Bushey, and M. Goeldner
Interaction of Non-competitive Blockers within the gamma -Aminobutyric Acid Type A Chloride Channel Using Chemically Reactive Probes as Chemical Sensors for Cysteine Mutants
J. Biol. Chem., September 3, 1999; 274(36): 25350 - 25354.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martinez-Torres, A. E. Vazquez, M. M. Panicker, and R. Miledi
Cloning and functional expression of alternative spliced variants of the rho 1 gamma -aminobutyrate receptor
PNAS, March 31, 1998; 95(7): 4019 - 4022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Hackam, T.-L. Wang, W. B. Guggino, and G. R. Cutting
The N-terminal Domain of Human GABA Receptor rho 1 Subunits Contains Signals for Homooligomeric and Heterooligomeric Interaction
J. Biol. Chem., May 23, 1997; 272(21): 13750 - 13757.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martinez-Torres and R. Miledi
Expression of gamma -aminobutyric acid rho 1 and rho 1Delta 450 as gene fusions with the green fluorescent protein
PNAS, February 13, 2001; 98(4): 1947 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martinez-Torres, A. Demuro, and R. Miledi
GABArho 1/GABAAalpha 1 receptor chimeras to study receptor desensitization
PNAS, March 28, 2000; 97(7): 3562 - 3566.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics